JPRN-jRCT2051230128招募中1 期
ROH-001 ophthalmic solution phase I clinical trial -Single and multiple dose study
Mantani Tomomi0 个研究点目标入组 48 人开始时间: 2023年11月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 35age old（—）
- 性别
- Male
入选标准
- •Japanese healthy adult male, >=18 and <=35 of age, >=18.5 and <25.0 of BMI
排除标准
- •1) Subject with a serious history of eye, brain, liver, kidney, heart, lung, gastrointestinal, hematological, endocrine, metabolic, or neurological
- •2) Subjects with current or with a history of drug or alcohol abuse
研究者
相似试验
已完成
2 期
ROH-201 ophthalmic solution Phase 2a clinical trialDry eye diseaseJPRN-jRCT2051200158Kitano Takashi80
进行中（未招募）
2 期
ROH-201 ophthalmic solution phase IIb clinical trialDry eye diseaseJPRN-jRCT2031220368Mantani Tomomi300
进行中（未招募）
1 期
Phase I trial: Ocular Technology Group International CV23-08The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN66819383CooperVision International Ltd40
进行中（未招募）
1 期
Phase I trial: Ocular Technology Group InternationalThe Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN90702227CooperVision International Limited20
招募中
1 期
A phase I/IIa study of STN1014100 ophthalmic solution in healthy adult male volunteers and dry eye patientsDry eyeJPRN-jRCT2051220152Koji Oka134